Blueberries Medical Corp., a licensed producer of cannabis derivatives in Colombia, announced a non-brokered private placement raising approximately C$1.1 million by selling 84.6 million common shares at C$0.013 each. The funds will be used to expand operations, support general corporate needs, and enhance working capital. The offering is expected to close around August 26, 2026, and is led by Terraflos Inc., a key investor controlled by Blueberries' CEO. This financing supports Blueberries' growth in health, wellness, and longevity sectors through scalable production of plant-based bioactives and cannabis products.
Par Pacific Holdings (PARR) reported a record Q2 2026 adjusted EBITDA of $571 million, driven by a refining margin super cycle and its strong position in Hawaii. The company's system-wide margin capture reached 125%, well above historical and peer av...
Robinhood Chain has rapidly grown to 863,800 tokenized-stock holders in two months, driving daily trading volumes between $100M and $130M. This surge increased Robinhood Chain's fees and revenue, with daily fees hitting $6M and revenue $5.4M on Septe...
Solana's price remains bullish, trading near $103.25 with buyers defending support between $90.50 and $100.48. The network processed about five billion transactions in August and generated $42.28 million in weekly application revenue, highlighting st...
Arbitrum surged 45.95% to $0.1928, leading the day's top crypto gainers due to increased investor confidence in Ethereum layer-2 scaling solutions that reduce costs and improve speed. Other notable gainers included Pons, Uniswap, PancakeSwap, and Eth...
Resideo's Senior Vice President, Mehta, recently purchased 10,928 shares of the company's stock through a direct purchase valued at $226,000. This insider buying can signal confidence in the company's future prospects and may influence investor senti...
